Athersys to Host Fourth Quarter and Annual Financial Results Call

The Company is developing its MultiStem cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas.

http://ift.tt/1duPhSs